A Study to Evaluate the Safety & Effect of CFZ533 on Patients With Graves'

See also
Status	Clinical Trial	Phase
Completed	`NCT01950260` - Early Levothyroxine Post Radioactive Iodine	Phase 2/Phase 3
Completed	`NCT01269749` - Radioactive Iodide Therapy for Pediatric Graves' Disease	Phase 2
Recruiting	`NCT06068179` - Graves' Disease Remission Study: MycoMeth Combo	Phase 2/Phase 3
Recruiting	`NCT02114619` - Comparative Study of Different I-131 Doses in Graves' Disease	N/A
Completed	`NCT04383795` - Change of Gut Microbiome in the Treatment of Graves' Disease
Completed	`NCT02384668` - D-vitamin And Graves' Disease; Morbidity And Relapse Reduction	N/A
Completed	`NCT01885533` - Post-Radioiodine Graves' Management: The PRAGMA-Study	N/A
Completed	`NCT01534169` - Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients	Phase 1
Completed	`NCT00917241` - Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone	Phase 4
Completed	`NCT00004660` - Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy	N/A
Completed	`NCT02205801` - Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy	N/A
Recruiting	`NCT02620085` - Thyroid Disease and Personality Study	N/A
Completed	`NCT00958113` - Autoimmune Thyroid Disease Genetic Study	N/A
Completed	`NCT02727738` - Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole	N/A
Completed	`NCT00697528` - Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy	N/A
Completed	`NCT00150124` - Block-replacement Therapy During Radioiodine Therapy	Phase 4
Completed	`NCT03535090` - Coagulation After Intravenous Methylprednisolone Administration
Not yet recruiting	`NCT02373995` - Role of the Microbiome in Graves' Orbitopathy	Phase 1/Phase 2
Completed	`NCT00505011` - Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease	N/A
Completed	`NCT02107794` - Shared Decision Making in Graves Disease - Graves Disease (GD) Choice	N/A

NCT number	NCT02713256
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	April 19, 2016
Completion date	April 24, 2017

A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms